Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that its executives will participate ...

About Twist Bioscience Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the ...

Discovering Twist Bioscience: A Closer Look Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology.

the company has been attracting attention for its innovative approaches to DNA synthesis and storage. Twist Bioscience's financial performance has shown mixed results. InvestingPro analysis ...

We recently published a list of 10 Best Immunology Stocks To Buy Now. In this article, we are going to take a look at where ...

Twist Bioscience specializes in synthetic DNA and DNA-based products for various applications in life sciences. With a market capitalization of approximately $3.1 billion as of February 2025, the ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector ...